| PHUSE US |
2026 |
Statistical Programming Methods for Evaluating the Impact of Immunogenicity on Safety and Efficacy Outcomes |
Dinesh Putluri,
Rakesh Padigala |
source
presentation source |
10 |
| PHUSE APAC |
2026 |
Beyond Toxicity : Accelerating Dose -Finding with Pharmacokinetic -Driven Bayesian Design PKBOIN-12 |
Anetta Mary Xavier |
source
presentation source |
13 |
| PharmaSUG |
2025 |
Deciphering Exposure-Response Analysis Datasets: A Programmer-s Perspective for Oncology Studies |
Sabarinath Sundaram |
source |
6 |
| PHUSE US |
2025 |
Accelerating PKPD Analysis with Automated DDI Variable Creation: An SAS-Based Approach |
Sunil Mummidisetty,
Harish Ganesan |
source
presentation source |
7 |
| PHUSE US |
2025 |
Optimizing Development and Regulatory Submission of eSUB Package for Exposure-Response and PK/PD Analysis |
Saumilkumar Tripathi,
Ephicacy Lifescience |
source
presentation source |
10 |
| PHUSE EU |
2024 |
Revolutionising Literature Reviews with a GPT-Assisted Tool: Enhanced Search, Extraction and Visualisation |
Yingjia Chen,
Martin Schaerer |
source
presentation source |
12 |
| PharmaSUG CN |
2024 |
Implementation on concentration-QTc modeling |
Daoqing Li,
Deli Cao |
source |
20 |
| WUSS |
2022 |
Standardised MedDRA Queries (SMQs): Beyond the Basics; Weighing Your Options |
Richann J. Watson,
Karl Miller |
source |
8 |
| PharmaSUG |
2022 |
Standardised MedDRA Queries (SMQs): Beyond the Basics; Weighing Your Options |
Richann J. Watson,
Karl Miller |
source |
8 |
| PHUSE EU |
2021 |
Studyathons: A New Way of Organising and Promoting Multidisciplinary Collaborations in Biomedical Open Science [presentation] |
Julia Kurps,
Maria Escala-Garcia |
source
video |
22 |
| PharmaSUG |
2020 |
Risk-based and Exposure-based Adjusted Safety Incidence Rates |
Qiuhong Jia,
Fang-Ting Kuo,
Chia-Ling (Ally) Wu,
Ping Xu |
source |
8 |
| SGF |
2019 |
Real-World Evidence and Population Health Analytics: Intersection and Application |
David Olaleye |
source |
16 |
| PHUSE EU |
2018 |
Enhancing the Application of Real-world Evidence with Episode of Care Analytics |
David Olaleye,
Lina Clover |
source
presentation source |
13 |
| PHUSE US |
2018 |
Adverse Event Analysis - One step forward! |
Anuja Rasal |
source
presentation source |
11 |
| SGF |
2018 |
What's New at SAS for Health Care |
Lina Clover |
source |
9 |
| SESUG |
2017 |
Statistician's secret weapon: 20 ways of detecting raw data issues |
Lixiang Larry Liu |
source |
8 |
| PHUSE EU |
2017 |
Applying the OMOPCommon Data Model to Dutch Healthcare Data: A Case Study |
Rients van Wijngaarden |
source
presentation source |
5 |
| MWSUG |
2017 |
AIR Binder 2.0: A Dynamic Visualization, Data Analysis and Reporting SAS Application for Preclinical and Clinical ADME Assays, Pharmacokinetics, Metabolite Profiling and Identification |
Hao Sun,
Kristen Cardinal,
Richard Voorman |
|
26 |
| PharmaSUG |
2017 |
Statistician's secret weapon: 20 ways of detecting raw data issues |
Lixiang Larry Liu |
source |
8 |
| PHUSE EU |
2016 |
Device Domains: Examples of their Use in Clinical Trials |
Oksana Voevutska |
source
presentation source |
12 |
| PharmaSUG |
2016 |
Programming Support for Exposure-Response Analysis in Oncology Drug Development |
Peter Lu,
Hong Yan |
source |
8 |
| PharmaSUG |
2016 |
Swimmer Plot by Graphic Template Language (GTL) |
Baiming Wang |
source |
9 |
| PHUSE EU |
2014 |
Drug Exposure Plot: Tailored Approach to Display Ongoing Data |
Mathias Lebreton |
source
presentation source |
12 |
| PharmaSUG |
2014 |
Considerations in the Submission of Exposure Data in SDTM-Based Datasets |
Fred Wood,
Jerry Salyers,
Richard Lewis,
Kristin Kelly |
source |
6 |
| PharmaSUG |
2012 |
Accessing Microsoft Excel Workbook Cell Attributes from within SAS v9 |
Timothy J. Harrington |
source |
9 |
| NESUG |
2010 |
Counting Drug Exposure in SAS with Interval Graph Modeling |
Xiaoqiang Wang |
|
10 |
| PharmaSUG |
2007 |
Graphical Patient Profiles |
David Stokar |
|
8 |
HOME
QUICK SEARCH
AUTHORS
KEYWORDS
HELP
BUGS